Twenty21 is now live

About Project Twenty21 Project Twenty21 is a registry aiming to monitor the health outcomes of 20,000 patients using cannabis based medicinal products (CBMPs), creating the largest body of evidence in Europe for the safety and efficacy of CBMPs. Drug Science hope that the findings of Project Twenty21 will provide evidence for NHS funding where the  …


Prescribed CBD could help people quit cannabis

A benchmark clinical trial published today shows that cannabidiol (CBD) could be a safe and effective treatment for problematic cannabis use.  Results from the first-ever randomised clinical trial of CBD for cannabis use disorder suggests that prescribed doses of the non-intoxicating constituent part of the cannabis plant could help people kick the habit. In the  …


Medical Cannabis: What Lessons Can Be Learned for the UK?

Article from Drug Science’s Head of Research – Dr Anne Schlag An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK? Despite the legalization of medical cannabis in the UK in November 2018, patients still lack access to this medicine, with fewer than 10 NHS prescriptions having been written  …